Fevertree Drinks plc (FEVR), the premium mixer brand listed on the London Stock Exchange, has disclosed a share buyback covering the period from 9 November to 13 November 2026. The company purchased a total of 166,742 ordinary shares of £0.0025 each through its broker, Investec Bank plc, across both the XLON and AIMX venues. The purchases were made under authority granted by shareholders at Fever-Tree's 2025 Annual General Meeting held on 5 June 2025, and the company has confirmed it intends to cancel all shares acquired. Investors in the premium beverages sector may note the price progression across the five-day window.

Key Points

  • Fevertree Drinks plc (FEVR) — premium tonic water and mixer brand traded on the London Stock Exchange
  • The company purchased 166,742 ordinary shares between 9 and 13 November 2026 via Investec Bank plc, with all shares to be cancelled
  • Volume-weighted average prices ranged from approximately 923p to 975p; individual share prices spanned 912p to 981.5p across the period
  • Investors should watch for further buyback tranches under the 2025 AGM authority and any update to the total shares in issue following cancellation

Fever-Tree's Five-Day Buyback Covers XLON and AIMX Venues via Investec Bank

The buyback activity took place across five trading days, with purchases executed on the London Stock Exchange's main market (XLON) on each day and an additional block of 10,000 shares transacted on the AIMX venue on 10 November 2026. Investec Bank plc acted as broker for all transactions on behalf of Fever-Tree. The announcement states that a full breakdown of individual trades has been published in accordance with Article 5(1)(b) of the UK Market Abuse Regulation, as retained in domestic law via the European Union (Withdrawal) Act 2018.

Daily Volume and Price Data Show Upward Trajectory Through the Week

On 9 November 2026, Fever-Tree purchased 35,172 shares at a volume-weighted average price (VWAP) of 927.27p, with prices ranging from 920.5p to 935p. By 13 November, the VWAP had risen to 975.13p, with the highest price recorded across the full period reaching 981.5p. The lowest price paid during the five days was 912p on 11 November. Daily aggregated volumes were broadly consistent, ranging from 25,075 on 10 November on XLON to 32,561 on 13 November, suggesting steady and measured execution throughout the buyback window.

Shareholder Authority Granted at 2025 AGM Underpins the Cancellation Programme

The buyback programme operates under authority explicitly approved by Fever-Tree shareholders at the company's 2025 Annual General Meeting, held on 5 June 2025. The company has confirmed its intention to cancel all purchased ordinary shares rather than hold them in treasury, which will reduce the total number of shares in issue accordingly. Share cancellations of this nature can affect earnings-per-share calculations over time, though the company has not provided specific guidance on the overall scale or duration of the buyback programme in this announcement.